LIFECARE AS Inactive Instrument
Lifecare AS Stock Oslo Bors
Equities
NO0010591191
Biotechnology & Medical Research
| Sales 2024 * | 8.7M 797K | Sales 2025 * | 70.5M 6.46M | Capitalization | 485M 44.42M |
|---|---|---|---|---|---|
| Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 47.3 x |
| Net cash position 2024 * | 72.9M 6.68M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 6.88 x |
| P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 48.97% |
More Fundamentals
* Assessed data
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Joacim Holter
CEO | Chief Executive Officer | 48 | 10-12-31 |
Andreas Pfützner
CTO | Chief Tech/Sci/R&D Officer | 63 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 66 | 21-05-07 | |
Bo Petersson
BRD | Director/Board Member | - | 20-11-19 |
Lutz Heinemann
BRD | Director/Board Member | - | 20-11-19 |
Lifecare AS is a Norway-based company that develops miniaturized and implantable nanobiosensors for correct and continuous monitoring of glucose and other biomarkers. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.
Calendar
2024-04-29
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| +3.13% | 42.11B | |
| +48.83% | 40.08B | |
| +8.49% | 40B | |
| -10.82% | 26.87B | |
| +8.26% | 24.58B | |
| -23.69% | 18.44B | |
| +1.58% | 11.94B | |
| +32.83% | 11.66B | |
| +6.63% | 11.01B |
